SEC. 4. STRENGTHENING ACCESS TO CANCER SCREENING 
FOR WOMEN. 
Part B of title III of the Public Health Service Act 
(42 U.S.C. 243 et seq.) is amended by inserting after sec-
tion 317P the following: 
‘‘SEC. 317P–1. GRANTS FOR WOMEN’S HEALTH CARE PRO-
VIDERS. 
‘‘(a) IN GENERAL.—The Secretary is authorized to 
make grants and to enter into contracts with public or 
nonprofit private entities to expand preventive health serv-
ices, including the cancer screening services required to 
be covered by group health plans and health insurance 
coverage pursuant to section 2713(a)(4). In awarding 
such grants, the Secretary shall seek to increase access 
to critical, life-saving cancer screening, cervical cytology 
(commonly 
referred 
to 
as 
‘Pap 
tests’), 
human 
papillomavirus tests, human papillomavirus and Pap co- 
tests, human papillomavirus vaccinations, and diagnostic 
tests for women with cancer symptoms, particularly 
women of color. 
‘‘(b) AUTHORIZATION OF APPROPRIATIONS.—There 
is authorized to be appropriated to carry out this section, 
$20,000,000 for each of fiscal years 2025 through 2027.’’. 
VerDate Sep 11 2014 
19:45 Dec 30, 2024
Jkt 059200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6201
E:\BILLS\H10287.IH
H10287
ssavage on LAPJG3WLY3PROD with BILLS
SEC. 5. EXPANDING CANCER SCREENING PROVIDER TRAIN-
ING. 
Part B of title III of the Public Health Service Act 
(42 U.S.C. 243 et seq.), as amended by section 4, is fur-
ther amended by inserting after section 317P–1 the fol-
lowing: 
‘‘SEC. 317P–2. WOMEN’S HEALTH CARE PROVIDERS DEM-
ONSTRATION TRAINING PROJECT. 
‘‘(a) ESTABLISHMENT OF PROGRAM.—The Secretary 
shall establish a demonstration program to award 3-year 
grants to eligible entities for the training of physicians, 
nurse practitioners, physician assistants, and other health 
care providers related to life-saving breast and gynecologic 
cancer screening for women, including appropriate follow- 
up care and screening for abnormal results. 
‘‘(b) PURPOSE.—The purpose of the program under 
this section is to enable each grant recipient to— 
‘‘(1) provide to licensed physicians, nurse prac-
titioners, physician assistants, and other health care 
providers, through clinical training, education, and 
practice, the most up-to-date clinical guidelines, re-
search, and recommendations adopted by the United 
States Preventive Services Task Force in the area of 
preventive 
cancer 
screening 
for 
breast 
and 
gynecologic cancers, including for women with dense 
breast tissue; 
VerDate Sep 11 2014 
19:45 Dec 30, 2024
Jkt 059200
PO 00000
Frm 00007
Fmt 6652
Sfmt 6201
E:\BILLS\H10287.IH
H10287
ssavage on LAPJG3WLY3PROD with BILLS
‘‘(2) establish a model of training for physi-
cians, nurse practitioners, physician assistants, and 
other health care providers that specialize in wom-
en’s health care, with a specific focus on breast and 
gynecologic cancer screening and follow up care, that 
may be replicated nationwide; 
‘‘(3) train physicians, nurse practitioners, phy-
sician assistants, and other health care providers to 
serve rural and underserved communities, low-in-
come communities, and communities of color in 
breast and gynecologic cancer screening and follow 
up care; and 
‘‘(4) provide implicit bias, cultural competency, 
and patient-centered communication training cov-
ering the ways in which structural racism and dis-
crimination manifest within the medical field and 
perpetuate racial disparities in gynecologic cancer in-
cidence and mortality rates and how to communicate 
with patients through a knowledgeable and culturally 
empathetic lens. 
‘‘(c) ELIGIBLE ENTITIES.—To be eligible to receive 
a grant under this section, an entity shall be— 
‘‘(1) an entity that receives funding under sec-
tion 1001 or section 1003; 
VerDate Sep 11 2014 
19:45 Dec 30, 2024
Jkt 059200
PO 00000
Frm 00008
Fmt 6652
Sfmt 6201
E:\BILLS\H10287.IH
H10287
ssavage on LAPJG3WLY3PROD with BILLS
‘‘(2) an essential community provider, as de-
fined in section 156.235 of title 45, Code of Federal 
Regulations (or any successor regulations), that is 
primarily engaged in family planning; 
‘‘(3) an entity that furnishes items or services 
to individuals enrolled in a State Medicaid program 
or waiver of such a plan; or 
‘‘(4) an entity that, at the time of application, 
provides cancer screening services under the Na-
tional Breast and Cervical Cancer Early Detection 
Program under title XV.’’. 
SEC. 6. STUDY AND REPORT TO CONGRESS ON INCREASED 
CANCER SCREENING FOR WOMEN. 
(a) IN GENERAL.—The Secretary of Health and 
Human Services (referred to in this section as the ‘‘Sec-
retary’’) shall— 
(1) conduct a study (and periodically update 
such study) on increased access to women’s preven-
tive life-saving cancer screenings across the United 
States; and 
(2) not later than 2 years after the date of en-
actment of this Act, and every 5 years thereafter, 
submit a report to Congress on such study. 
(b) CONTENTS.—The study and reports under sub-
section (a) shall include— 
VerDate Sep 11 2014 
19:45 Dec 30, 2024
Jkt 059200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H10287.IH
H10287
ssavage on LAPJG3WLY3PROD with BILLS
(1) an analysis of breast and gynecologic cancer 
rates among women across all 50 States, the Dis-
trict of Columbia, and the territories, including by 
geographic area, income, employment status, race, 
ethnicity, and status of insurance coverage; 
(2) an analysis of cancer screenings provided by 
women’s health care providers across all 50 States, 
the District of Columbia, and the territories, includ-
ing clinical breast exams, other screening for breast 
cancer, and screening for cervical cancer, ovarian 
cancer, and other gynecologic cancers; 
(3) with respect to women with disproportionate 
rates of gynecological cancers, or who are less likely 
to receive screenings and care, and broken down by 
categories of such women that include African-Amer-
ican women, Hispanic and Latina women, older 
women, uninsured and underinsured women, and 
women living in rural and underserved areas— 
(A) an analysis of the awareness, avail-
ability, and uptake of breast, cervical, ovarian, 
and other gynecological cancer screening op-
tions; 
(B) an analysis of how access to health 
care providers trained under the program de-
scribed in section 317P–2 of the Public Health 
VerDate Sep 11 2014 
19:45 Dec 30, 2024
Jkt 059200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H10287.IH
H10287
ssavage on LAPJG3WLY3PROD with BILLS